Skip to content

Efficacy at One Year of Combined Injections of Plasma Rich in Platelets and Hyaluronic Acid in Knee Osteoarthritis

Efficacy at One Year of Combined Injections of Plasma Rich in Platelets and Hyaluronic Acid in Knee Osteoarthritis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05039463
Acronym
ISPAG
Enrollment
100
Registered
2021-09-09
Start date
2021-08-16
Completion date
2026-06-01
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyaluronic Acid, Knee Osteoarthritis, Platelet Rich Plasma

Keywords

platelet rich plasma, hyaluronic acid, Knee Osteoarthritis

Brief summary

The French Society of Rheumatology cannot rule on the value of intra-articular injections of PRP due to the lack of hindsight and insufficient data. In fact, the injection protocols are very heterogeneous in terms of preparation method, the presence or not of leukocytes, the number of centrifugations, the volume injected, the ultrasound guidance, which makes it difficult to analyze the literature. The investigator objective is therefore to evaluate the effectiveness of combined injections of PRP and hyaluronic acid.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age : \> 18 years old * Patients benefiting, in the context of knee osteoarthritis, from viscosupplementation alone or from two injections of PRP, in combination with HA, at the Amiens University Hospital.

Exclusion criteria

* Patient refusal to use the data * Language barrier * Age less than 18 years old.

Design outcomes

Primary

MeasureTime frame
change of the visual analogue scale (VAS) from the "PRP + HA" group on the "HA alone" groupup to one year

Countries

France

Contacts

CONTACTLAURE LE MONNIER, MD
lemonnier.laure@chu-amiens.fr03 22 66 82 50

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 16, 2026